Integral Diagnostics | IDX - Equity Capital And Reserves


Integral Diagnostics reported AUD301.71M in Equity Capital and Reserves for its fiscal semester ending in June of 2024.





Equity Capital And Reserves Change Date
Alcidion AUD 89.64M 1.84M Dec/2025
Ansell USD 1.97B 10.2M Dec/2025
Cochlear AUD 1.94B 12.2M Dec/2025
CSL USD 18.66B 2.75B Dec/2025
Healius AUD 1.03B 13.9M Dec/2024
Mayne Pharma AUD 454.19M 93.58M Jun/2024
Monash IVF AUD 253.91M 3.49M Dec/2025
Nanosonics AUD 219.69M 9.78M Dec/2025
Polynovo AUD 83.14M 121K Dec/2025
Ramsay Health Care AUD 4.79B 916.1M Dec/2025
ResMed USD 6.32B 199.62M Dec/2025
Sigma Healthcare AUD 4.67B 3.8B Dec/2025
Sonic Healthcare AUD 8.2B 120.9M Dec/2024
Telix Pharmaceuticals AUD 416.86M 5.08M Dec/2025